Edition:
India

aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Capital Market

4.22USD
17 Sep 2020
Change (% chg)

-- (--)
Prev Close
$4.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
19,878
52-wk High
$7.62
52-wk Low
$2.15

Latest Key Developments (Source: Significant Developments)

Atyr Pharma Files For Offering Of 2.5 Mln Shares Of Common Stock - SEC Filing
Monday, 27 Jan 2020 

Jan 27 (Reuters) - aTyr Pharma Inc ::ATYR PHARMA INC FILES FOR OFFERING OF 2.5 MILLION SHARES OF COMMON STOCK - SEC FILING.  Full Article

aTyr Pharma Inc Reports Q3 Loss Per Share Of $1.47
Friday, 15 Nov 2019 

Nov 14 (Reuters) - aTyr Pharma Inc ::ATYR PHARMA ANNOUNCES THIRD QUARTER 2019 RESULTS AND PROVIDES CORPORATE UPDATE.Q3 LOSS PER SHARE $1.47.AS OF SEPT. 30 HAD $38.1 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS.FOR YEAR ENDING 2019, ATYR IS MAINTAINING ITS PRIOR GUIDANCE ON TOTAL CASH BURN.  Full Article

Atyr Pharma Files For Mixed Shelf Of Up To $20 Million – SEC Filing
Wednesday, 22 May 2019 

May 22 (Reuters) - aTyr Pharma Inc ::ATYR PHARMA INC FILES FOR MIXED SHELF OF UP TO $20 MILLION – SEC FILING.  Full Article

aTyr Pharma Qtrly Loss Per Share $0.18
Tuesday, 14 May 2019 

May 13 (Reuters) - aTyr Pharma Inc ::ATYR PHARMA ANNOUNCES FIRST QUARTER 2019 RESULTS AND PROVIDES CORPORATE UPDATE.ATYR PHARMA INC - QTRLY LOSS PER SHARE $0.18.ATYR PHARMA INC - AS OF MARCH 31, 2019, ATYR HAD $43.0 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS..ATYR PHARMA - SUBSEQUENT TO QUARTER-END, CO RAISED $5 MILLION IN GROSS PROCEEDS THROUGH REGISTERED DIRECT INVESTMENT LED BY FEDERATED KAUFMANN SMALL CAP FUND.  Full Article

ATyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring
Monday, 11 Mar 2019 

March 11 (Reuters) - aTyr Pharma Inc ::ATYR PHARMA ANNOUNCES RESEARCH COLLABORATION WITH GLOBAL BIOTHERAPEUTICS LEADER CSL BEHRING.ATYR PHARMA INC - ATYR ELIGIBLE TO RECEIVE UP TO $17 MILLION IN POTENTIAL OPTION FEES.ATYR PHARMA INC - CSL BEHRING WILL PAY A TOTAL OF UP TO $4.25 MILLION PER SYNTHETASE PROGRAM.ATYR PHARMA - ATYR WILL GRANT CSL BEHRING OPTION TO NEGOTIATE LICENSES FOR WORLDWIDE RIGHTS TO EACH IND CANDIDATE THAT EMERGES FROM COLLABORATION.  Full Article

BRIEF-Atyr Pharma Highlighted New External Research Demonstrating Involvement Of Neuropilin Biology In Sars-Cov-2 Infection

* ATYR PHARMA INC - HIGHLIGHTED NEW EXTERNAL RESEARCH DEMONSTRATING INVOLVEMENT OF NEUROPILIN BIOLOGY IN SARS-COV-2 INFECTION